OPKO Health's (OPK) ModeX Therapeutics Forms Scientific Advisory Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to OPKO Health's (OPK) ModeX Therapeutics Forms Scientific Advisory Board

OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development

June 9, 2025 8:00 AM EDT

Will provide expertise across ModeXs portfolio of next generation multispecific antibodies for complex diseases involving the immune system, including cancer

ModeXs promising immunology pipeline includes first-in class drugs with two assets in ongoing clinical trials and multiple pre-IND assets to enter clinical trials

WESTON, Mass., June 09, 2025 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health company (NASDAQ: OPK), today announced the creation of a Scientific Advisory Board to provide counsel and insight into the development of ModeXs immunology and oncology-focused pipeline featuring potential... More